Identification of a 5-gene signature panel for the prediction of prostate cancer progression

Our study presents a new 5-gene signature panel that is associated with worse clinical prognosis and is elevated in prostate cancer metastasis on both protein and mRNA levels. Our 5-gene signature panel represents a potential modality for the prediction of prostate cancer progression towards the onset of metastasis.

Authors

Institutions

Publication Details

Journal
British Journal of Cancer
Published
2024-10-14
DOI
https://doi.org/10.1038/s41416-024-02854-w
Citations
2
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of a 5-gene signature panel for the prediction of prostate cancer progression

Sharon J. Pitteri, Chia‐Nung Hung, Shiqin Liu, Michael A. Liss et al.
2 citations
British Journal of Cancer
Prostate Cancer Treatment and Research
0.84
article

Identification of a 5-gene signature panel for the prediction of prostate cancer progression

Sharon J. Pitteri, Chia‐Nung Hung, Shiqin Liu, Michael A. Liss, Arvind Muruganantham, Michelle Shen, James R. White, Tim H.‐M. Huang, Meghan A. Rice, Chun-Liang Chen, Kelsey Thompson, Tanya Ivanova Stoyanova, Fernando Jose Garcia-Marques, Kenneth J. Pienta, Zhao Zhang, Abel Bermudez
article en
2 citations

Abstract

Our study presents a new 5-gene signature panel that is associated with worse clinical prognosis and is elevated in prostate cancer metastasis on both protein and mRNA levels. Our 5-gene signature panel represents a potential modality for the prediction of prostate cancer progression towards the onset of metastasis.

British Journal of CancerVol. 131(11)
Johns Hopkins University (US), University of California, Los Angeles (US), The University of Texas at San Antonio Health Science Center (US), Johns Hopkins Medicine (US), Urology San Antonio (US), Resphera Biosciences (US), The University of Texas Health Science Center (US), The University of Texas Health Science Center at Houston (US), Stanford University (US)
National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 24%
Prostate Cancer Treatment and Research
0.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.